Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/08/04 Phase II trial of functional imaging-optimized stereotactic fractionated radiotherapy plus temozolomide for recurrent high-grade glioma.        

06/08/04 Phase II trial of iodine 131-labeled murine anti-tenascin monoclonal anti-body 81C6 (M81C6) via surgically created resection cavity in the treatment of patients with recurrent malignant brain tumors.        

06/08/04 Phase II trial of radiosurgery (RS) for 1 to 3 newly diagnosed brain metastases from renal cell, melanoma, and sarcoma: An Eastern Cooperative Oncology Group Study (E6397).        

06/08/04 Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG).        

06/08/04 Radiotherapy and concomitant weekly carboplatin and daily etoposide for patients with inoperable biopsy proven glioblastoma multiforme.        

06/08/04 Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group).        

06/08/04 Specific therapy for high-grade glioma by convection-enhanced delivery of the TGF-β2 specific antisense oligonucleotide AP 12009.        

06/08/04 Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study.        

06/08/04 Temozolomide combined with radiation as first-line treatment in primary glioblastoma multiforme: Phase I/II-study.        

06/08/04 Temozolomide for the treatment of recurrent glioma: Results of a compassionate use program in Belgium.        

06/08/04 The familiality of primary brain tumors as studied in the Utah Population Database (UPDB).        

06/08/04 Updated results from NABTT CNS consortium studies in primary CNS lymphoma.        

06/08/04 Drug treatment is first major improvement in brain cancer in decades        

06/08/04 Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.        

06/08/04 Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience.        

06/08/04 Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas.        

06/08/04 The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.        

06/08/04 Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.        

06/08/04 Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study.        

---

Displaying Stories 5161 to 5180 of 7668
Previous 20           Next 20